DIPLOMAT PHARMACY, INC.
DPLO
DPLO was delisted on the 7th of February, 2020.
0 hedge funds and large institutions have $0 invested in DIPLOMAT PHARMACY, INC. in 2020 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $1K → $0 (-$1K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| 1 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$1K |
DPLO Hedge Fund Activity: Q2 2020 in Review
0 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q2 2020, worth a combined $0 — down 100% from $1K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of DPLO and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Glenmede Trust, exiting entirely with an estimated $1K sold.
- 0 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q2 2020, down from 1 in Q1 2020.
- Funds reported $0 of DIPLOMAT PHARMACY, INC. stock for Q2 2020, down 100% quarter-over-quarter.
- 0 funds opened new DIPLOMAT PHARMACY, INC. positions in Q2 2020 and 1 closed out, a net change of -1 holder.
- The largest DIPLOMAT PHARMACY, INC. seller in Q2 2020 was Glenmede Trust, an estimated $1K sold.
Based on aggregated 13F filings for Q2 2020.